LLY

1,004.73

-1.24%↓

JNJ

246.64

-0.78%↓

ABBV

233.5

-0.27%↓

NVS

164.14

-1.37%↓

AZN

200.79

-1.4%↓

LLY

1,004.73

-1.24%↓

JNJ

246.64

-0.78%↓

ABBV

233.5

-0.27%↓

NVS

164.14

-1.37%↓

AZN

200.79

-1.4%↓

LLY

1,004.73

-1.24%↓

JNJ

246.64

-0.78%↓

ABBV

233.5

-0.27%↓

NVS

164.14

-1.37%↓

AZN

200.79

-1.4%↓

LLY

1,004.73

-1.24%↓

JNJ

246.64

-0.78%↓

ABBV

233.5

-0.27%↓

NVS

164.14

-1.37%↓

AZN

200.79

-1.4%↓

LLY

1,004.73

-1.24%↓

JNJ

246.64

-0.78%↓

ABBV

233.5

-0.27%↓

NVS

164.14

-1.37%↓

AZN

200.79

-1.4%↓

Search

Atara Biotherapeutics Inc

Closed

SectorHealthcare

5.38 10.7

Overview

Share price change

24h

Current

Min

4.65

Max

5.54

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+22.2% upside

Dividends

By Dow Jones

Next Earnings

5 Mar 2026

News Sentiment

By Acuity

20%

80%

39 / 352 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bearish Evidence

Atara Biotherapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

12 Jan 2026, 15:39 UTC

Major Market Movers

Atara Biotherapeutics Stock Falls After Surprise FDA Refusal to Approve Ebvallo

7 Mar 2025, 21:54 UTC

Earnings

Atara Biotherapeutics to Cut Half of Workforce Amid Restructuring

Peer Comparison

Price change

Atara Biotherapeutics Inc Forecast

Price Target

By TipRanks

22.2% upside

12 Months Forecast

Average 6 USD  22.2%

High 6 USD

Low 6 USD

Based on 1 Wall Street analysts offering 12 month price targets forAtara Biotherapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

1 ratings

0

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

7.245 / 7.64Support & Resistance

Short Term

Weak Bearish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

39 / 352 Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

$

help-icon Live chat